These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20490932)

  • 1. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
    Beer AJ; Eiber M; Souvatzoglou M; Holzapfel K; Ganter C; Weirich G; Maurer T; Kübler H; Wester HJ; Gaa J; Krause BJ
    Mol Imaging Biol; 2011 Apr; 13(2):352-61. PubMed ID: 20490932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
    Vag T; Heck MM; Beer AJ; Souvatzoglou M; Weirich G; Holzapfel K; Rummeny EJ; Schwaiger M; Krause BJ; Eiber M
    Eur Radiol; 2014 Aug; 24(8):1821-6. PubMed ID: 24889997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
    Contractor K; Challapalli A; Barwick T; Winkler M; Hellawell G; Hazell S; Tomasi G; Al-Nahhas A; Mapelli P; Kenny LM; Tadrous P; Coombes RC; Aboagye EO; Mangar S
    Clin Cancer Res; 2011 Dec; 17(24):7673-83. PubMed ID: 22038995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging.
    Eiber M; Beer AJ; Holzapfel K; Tauber R; Ganter C; Weirich G; Krause BJ; Rummeny EJ; Gaa J
    Invest Radiol; 2010 Jan; 45(1):15-23. PubMed ID: 19996762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P
    PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
    Heck MM; Souvatzoglou M; Retz M; Nawroth R; Kübler H; Maurer T; Thalgott M; Gramer BM; Weirich G; Rondak IC; Rummeny EJ; Schwaiger M; Gschwend JE; Krause B; Eiber M
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):694-701. PubMed ID: 24297503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer.
    Oprea-Lager DE; Vincent AD; van Moorselaar RJ; Gerritsen WR; van den Eertwegh AJ; Eriksson J; Boellaard R; Hoekstra OS
    PLoS One; 2012; 7(10):e48430. PubMed ID: 23119014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology.
    Li F; Hu J; Jiang H; Sun Y
    J Infect Public Health; 2020 Sep; 13(9):1347-1353. PubMed ID: 31289005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
    Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
    Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI,
    Kitajima K; Yamamoto S; Kawanaka Y; Nakanishi Y; Yamada Y; Go S; Kanematsu A; Kaida H; Yamakado K
    Hell J Nucl Med; 2020; 23(1):34-39. PubMed ID: 32222730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
    Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
    Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.
    Hardie AD; Rieter WJ; Bradshaw ML; Gordon LL; Young MA; Keane TE
    World J Urol; 2013 Dec; 31(6):1327-32. PubMed ID: 23595605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.
    Noto B; Eveslage M; Auf der Springe K; Exler A; Faldum A; Heindel W; Milachowski S; Roll W; Schäfers M; Stegger L; Bauer J
    Eur Radiol; 2024 Jul; 34(7):4504-4515. PubMed ID: 38099965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
    Rietbergen DD; van der Hiel B; Vogel W; Stokkel MP
    Nucl Med Commun; 2011 Dec; 32(12):1143-7. PubMed ID: 22045476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.